Stay updated on CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial

Sign up to get notified when there's something new on the CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification in the pharmacokinetic and pharmacodynamic data comparison between CHS-1701 and Neulasta in a clinical study involving healthy subjects.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:47.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, body weight, BMI, and health conditions required for inclusion, as well as exclusion criteria such as previous exposure to certain drugs and specific health conditions.
    Difference
    17%
    Check dated 2024-05-22T21:04:33.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:34:04.000Z thumbnail image

Stay in the know with updates to CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial page.